TLSI
TriSalus Life Sciences Reports Strong Q4 2025 Earnings with Revenue Growth Guidance Achieved
TriSalus Life Sciences, a leading life sciences company, recently reported its Fourth Quarter 2025 earnings call, showcasing strong revenue growth and key strategic moves to drive future expansion. According to the conference call transcript, TriSalus achieved fourth-quarter revenues of $13.2 million and full-year revenues of $45.2 million, representing